These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25122694)

  • 1. Second-line chemotherapy in advanced biliary cancer: the present now will later be past.
    Vivaldi C; Fornaro L; Cereda S; Aprile G; Santini D; Silvestris N; Lonardi S; Leone F; Milella M; Brandi G; Vasile E
    Ann Oncol; 2014 Dec; 25(12):2443-2444. PubMed ID: 25122694
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to the letter to the editor 'second-line chemotherapy in advanced biliary cancer: the present now will later be past' by Vivaldi et al.
    Lamarca A; Hubner RA; Ryder WD; Valle JW
    Ann Oncol; 2014 Dec; 25(12):2444-2445. PubMed ID: 25139549
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract Cancer.
    Jung JH; Lee HS; Jo JH; Cho IR; Chung MJ; Bang S; Park SW; Song SY; Park JY
    Chemotherapy; 2017; 62(6):361-366. PubMed ID: 28848173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy in biliary tract cancer.
    Tonini G; Frato ME; Vincenzi B; Santini D
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):371-4. PubMed ID: 20496551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development for combination of surgery and chemotherapy on biliary tract cancer].
    Kato A; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Furukawa K; Yoshitomi H; Mitsuhashi N; Takeuchi D; Takayashiki T; Suda K; Takano S; Miyazaki M
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1685-89. PubMed ID: 18975457
    [No Abstract]   [Full Text] [Related]  

  • 6. Response letter to "Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers".
    Ichimura T
    J Oncol Pharm Pract; 2023 Jun; 29(4):1025-1026. PubMed ID: 36927219
    [No Abstract]   [Full Text] [Related]  

  • 7. [Surgical outcome of biliary tract cancer with neoadjuvant chemotherapy].
    Kato A; Shimizu H; Yoshidome H; Otsuka M; Furukawa K; Yoshitomi H; Takeuchi D; Takayashiki T; Kuboki S; Suzuki D; Nakajima M; Miyazaki M
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1486-9. PubMed ID: 23133873
    [No Abstract]   [Full Text] [Related]  

  • 8. [Surgical outcome of biliary tract cancer with postoperative chemotherapy].
    Sugawara G; Ebata T; Yokoyama Y; Igami T; Kokuryo T; Tsunoda N; Fukaya M; Uehara K; Itatsu K; Yoshioka Y; Nagino M
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1483-5. PubMed ID: 23130375
    [No Abstract]   [Full Text] [Related]  

  • 9. Second-line chemotherapy in patients with advanced or recurrent biliary tract cancer: a single center, retrospective analysis of 294 cases.
    Takahara N; Nakai Y; Isayama H; Sasaki T; Saito K; Oyama H; Kanai S; Suzuki T; Sato T; Hakuta R; Ishigaki K; Takeda T; Saito T; Mizuno S; Kogure H; Tada M; Koike K
    Invest New Drugs; 2018 Dec; 36(6):1093-1102. PubMed ID: 30324343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy and histological stratification of biliary tract cancers.
    Cariati A; Piromalli E
    Oncology; 2012; 82(6):352-3. PubMed ID: 22677952
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study.
    Kus T; Aktas G; Kalender ME; Sevinc A; Camci C
    J Gastrointest Cancer; 2017 Jun; 48(2):170-175. PubMed ID: 27714651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral chemotherapy with doxifluridine and folinic acid in biliary tract cancer.
    Colleoni M; Di Bartolomeo M; Di Leo A; Zilembo N; Carnaghi C; Pandolfi A; Rimassa L; Artale S; Bajetta E
    Eur J Cancer; 1995 Dec; 31A(13-14):2426-7. PubMed ID: 8652289
    [No Abstract]   [Full Text] [Related]  

  • 13. Biliary cancers, chemotherapy, and cetuximab.
    Malka D; Boige V; Ducreux M
    Lancet Oncol; 2010 Dec; 11(12):1110-2. PubMed ID: 21126684
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinoma.
    Sun W; Patel A; Normolle D; Patel K; Ohr J; Lee JJ; Bahary N; Chu E; Streeter N; Drummond S
    Cancer; 2019 Mar; 125(6):902-909. PubMed ID: 30561756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary tract cancers: molecular profiling as a tool for treatment decisions. A literature review.
    Berardi R; Scartozzi M; Freddari F; Squadroni M; Santinelli A; Bearzi I; Fabris G; Cascinu S
    Cancer Treat Rev; 2006 Aug; 32(5):333-47. PubMed ID: 16762510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Itraconazole After First-line Chemotherapy on Survival of Patients with Metastatic Biliary Tract Cancer.
    Tsubamoto H; Sonoda T; Ikuta S; Tani S; Inoue K; Yamanaka N
    Anticancer Res; 2015 Sep; 35(9):4923-7. PubMed ID: 26254389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-line therapies in advanced biliary tract cancers.
    Tella SH; Kommalapati A; Borad MJ; Mahipal A
    Lancet Oncol; 2020 Jan; 21(1):e29-e41. PubMed ID: 31908303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs for biliary cancer.
    Eckel F; Schmid RM
    Expert Opin Emerg Drugs; 2007 Nov; 12(4):571-89. PubMed ID: 17979600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging treatment with systemic chemotherapy and targeted agents for biliary cancers.
    Boku N
    Curr Opin Investig Drugs; 2010 Jun; 11(6):653-60. PubMed ID: 20496260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancers of the large bowel and hepatobiliary tract.
    Sun W; Haller D
    Cancer Chemother Biol Response Modif; 2003; 21():509-34. PubMed ID: 15338761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.